Anticancer Medicine Access
Cross-source consensus on Anticancer Medicine Access from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Risks & contraindications
Evidence quality
Other
Highlighted claims
- The study treated NEML inclusion, registration, and local production as upstream determinants of access rather than directly measuring availability or affordability. — Determinants of access to anticancer medicines in South Asia: a multimethod study
- South Asia faces rising cancer incidence and mortality that make anticancer medicine access increasingly important. — Determinants of access to anticancer medicines in South Asia: a multimethod study
- Access to anticancer medicines in South Asia is constrained by poor coordination between policy, regulation, and supply systems. — Determinants of access to anticancer medicines in South Asia: a multimethod study
- Financial constraints, weak regulation, import dependence, small markets, and limited manufacturing capacity all restrict access. — Determinants of access to anticancer medicines in South Asia: a multimethod study